Feb 25, 2025 | Publication
 TME Lab creates a microfluidic device to better understand the communication between a brain tumor and the immune system. A Novel Multicompartment Barrier-Free Microfluidic Device Reveals the Impact of Extracellular Matrix Stiffening and Temozolomide on Immune-Tumor...
Feb 6, 2025 | Publication
Publication in Small 🚀 New Research Alert! Our team is excited to share our latest publication in Small, where we introduce a novel barrier-free microfluidic device designed to study the tumor microenvironment in glioblastoma. 🧠Key Findings:✔️ Tumor-driven...
Aug 30, 2024 | Publication
New article published in Computers in Biology and Medicine about mathematical modelling of glioblastoma resistance to temozolomide Our latest research article on glioblastoma modelling, entitled “Modelling glioblastoma resistance to temozolomide. A mathematical model...
Apr 26, 2024 | Publication
The latest work by Claudia, HĂ©ctor and Ismael on microfluidic devices has been accepted forpublication on Biomimetics (MDPI)  Our members Claudia Olaizola, Hector Castro-Abril, Ismael PerisĂ© BadĂa, ignacio Ochoa Garrido and Sara Oliván GarcĂa have recently published...
Apr 8, 2024 | Publication
New Article published in International Journal of Molecular Sciences TME lab members have published a new research article entitled “Human Dermal Decellularized ECM Hydrogels as Scaffolds for 3D In Vitro Skin Aging Models” in the journal International Journal of...
Feb 14, 2024 | Publication
Organ-on-chip technology validated to verify the effect of a drug against glioblastoma. We are delighted to announce the publication of our article “Tetralol derivative NNC-55-0396 targets hypoxic cells in the glioblastoma microenvironment: an organ-on-chip...
